
EXEL Industries: first half 2022-2023 results
First half 2022–2023 results Return to profit levels in line with expectations |
H1 results (October 2022–March 2023) | 2021–2022 (€m) | 2022–2023 (€m) |
SALES | 406.9 | 483.1 |
RECURRING EBITDA1 | 17.4 | 29.0 |
% of sales | 4.3% | 6.0% |
CURRENT OPERATING INCOME (EBIT) | 7.2 | 15.8 |
% of sales | 1.8% | 3.3% |
Non‐recurring items | (1.9) | 0.1 |
Net financial income/(expense) | 0.3 | (8.3) |
Tax and share of profit of associates | (3.6) | (3.4) |
NET INCOME | 1.9 | 4.2 |
% of sales | 0.5% | 0.9% |
NET FINANCIAL DEBT | (154.6) | (176.4) |
Sales 6 months (October 2022–March 2023) | 2021–2022 | 2022–2023 | Change (reported) | Change (LFL2) | ||
Reported | Reported | €m | % | €m | % | |
AGRICULTURAL SPRAYING | 186.8 | 236.8 | +50.0 | +26.7% | +44.5 | +23.8% |
SUGAR BEET HARVESTERS | 39.2 | 53.8 | +14.6 | +37.4% | +15.3 | +39.0% |
LEISURE | 55.2 | 62.1 | +6.9 | +12.5% | +2.5 | +4.5% |
INDUSTRY | 125.7 | 130.4 | +4.7 | +3.7% | +3.1 | +2.5% |
EXEL Industries Group | 406.9 | 483.1 | +76.2 | +18.7% | +65.3 | +16.1% |
Sales
First half 2022–2023
EXEL Industries posted revenue of €483.1 million for the first half of 2022–2023, up 18.7% as reported and up 16.1% at constant foreign exchange rates and scope.
Agricultural spraying revenue increased in Europe and North America, still benefiting from a stable full order book over the next 6 to 12 months for all Group brands. The Sugar beet harvesting business posted solid revenue growth driven by sales of new generation sugar beet harvesters and demand in Eastern Europe. In the Garden business, after declining in 2022, the market returned to pre-COVID volumes but continued to be impacted by adverse weather conditions lasting up until now and inventory clearance among distributors. Industry volumes remained broadly stable except in Asia, where they continue to grow.
Results
Reported recurring EBITDA improved sharply to €29.0 million, or 6.0% of revenue. Several factors explain this increase:
- The easing of supply chain tension and the increase in production rates in support of a constantly well-stocked order book enabled Agricultural spraying to grow significantly. Ongoing momentum in North America and Asia/Oceania underpinned the Group’s various activities during the first half. The various price increases implemented over the past few months have allowed the Group to preserve the gross margin amid the upward trend.
- Overheads have increased due to strong inflation and the gradual resumption of marketing and communication expenses.
Net income for the first half of 2022–2023 totaled €4.2 million versus €1.9 million in 2022.
- Non-recurring income almost broke even at €0.1 million. Non-recurring items in 2021–2022 included impairment of assets located in the Ukrainian war zone.
- Net financial income/(expense) deteriorated sharply to a €8.3 million net expense due to changes in foreign exchange gains and losses: currency movements resulted in an unrealized loss of €6 million, whereas the Group recorded a €2 million gain last year. The loss was exacerbated by the increase in cost of debt due to interest rate hikes over the past few months, despite the conversion of part of the debt to fixed rates, and by the increase in net debt versus the previous year.
Balance sheet
Net financial debt at March 31, 2023 was €176.4 million, compared to €154.6 million in 2022. This increase, as expected and in line with seasonal trends, remained limited however after the high point reached at the end of September 2022 following the increase in inventories (mainly work-in-progress) to supply the substantial order book in Agricultural spraying and Sugar beet harvesting. Nevertheless, special attention is being paid to managing working capital across all Group business lines and this item is currently under control.
Outlook
- AGRICULTURAL SPRAYING
- The Group continues to adjust its selling prices in response to rising purchase costs.
- Despite the relative decline in agricultural product prices, order books remain well-stocked in all Group regions including Eastern Europe.
- Initial sales of the TRAXX autonomous high-clearance tractor are progressing in accordance with our forecasts and testing has begun on the TRAXX Hydrogen prototype.
- Sales of our 3S Spot Spray Sensor® precision spraying solution for large-scale crops were in line with our forecasts. Sales will accelerate over the coming months.
- SUGAR BEET HARVESTING
- The recent exceptional increase in sugar prices is expected to bolster new machine sales over the coming months. There is still a fair amount of arable land, except in France.
- LEISURE
- The market is impacted by weather conditions and inventory clearance among distributors. Provided weather conditions remain favorable, business is expected to return to volumes comparable to the pre-COVID period.
- INDUSTRY
- Regional trends are expected to remain the same in the three main markets marked by stabilization in Europe and North America and sustained growth in Asia.
Yves Belegaud, Chief Executive Officer of the EXEL Industries Group:
“An encouraging first half benefiting from a slight easing in supply chains and strong volume growth in agricultural equipment. The Group also benefits from a solid order book offering clear visibility over the coming quarters. Managing working capital remains a priority for the Group’s development.”
Upcoming events
- May 30, 2023: SFAF presentation of H1 2022–2023 results.
- July 25, 2023, before market opening: Q3 2022–2023 sales.
About EXEL Industries
EXEL Industries is a French family-owned group that designs, manufactures and markets capital equipment and provides
associated services that enable its customers to improve efficiency and productivity or enhance their well-being while achieving
their CSR objectives.
Driven by an innovation strategy for 70 years, EXEL Industries has based its development on innovative ideas designed to offer
customers unique, efficient, competitive and user-friendly products.
Since its inception, the Group has recorded significant growth in each of its markets through both organic growth and corporate
acquisitions, underpinned by a stable shareholder base guided by a long-term development strategy.
EXEL Industries employs approximately 3,770 permanent employees spread across 27 countries and five continents. The Group
posted FY 2021-2022 sales of €977 million.
Euronext Paris, SRD Long only – compartment B (Mid Cap) EnterNext© PEA-PME 150 index (symbol: EXE/ISIN FR0004527638)
Press release available onsitewww.EXEL-industries.com
Yves BELEGAUD Chief Executive Officer | Thomas GERMAIN Group Chief Financial Officer / Investor relations |
direction.communication@exel-industries.com |
1Recurring EBITDA = current operating income (EBIT) + depreciation and amortization of non-current assets + change in provisions (excluding provisions on current assets) + share of profit of associates
2Like-for-like (LFL) = at constant foreign exchange rates and scope
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Evaxion’s AI technology identifies cancer vaccine targets associated with longer progression-free survival of melanoma patients in the EVX-01 Phase 1 clinical trial3.6.2023 23:00:00 CEST | Press release
The clinical trial of the personalized cancer vaccine EVX-01 met its primary endpoints of safety and tolerabilityPositive clinical responses were reported in 8 out of 12 EVX-01 treated patientsHigh-quality neoantigens, predicted by AI technology, were associated with longer progression-free survivalStrong vaccine-specific immune responses were induced in all 12 EVX-01 treated patients Higher EVX-01 dose induced a stronger immune response and was associated with improved clinical outcome COPENHAGEN, Denmark, June 03, 2023 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage biotechnology company specializing in the development of AI-powered immunotherapies, today presented promising clinical data from its EVX-01 Phase 1 dose escalation trial in metastatic melanoma at the 2023 ASCO annual meeting in Chicago, Illinois. The Phase 1 trial successfully met primary endpoints for safety and tolerability of EVX-01 in metastatic melanoma patients
BW Offshore: Short-term contract extension for Espoir Ivoirien3.6.2023 16:39:00 CEST | Press release
Short-term contract extensionfor Espoir Ivoirien BW Offshore has signed a short-term extension for the lease and operation of the FPSO Espoir Ivoirien in order to discuss a potential purchase of the FPSO by the client. The firm period has been extended until 9 June 2023. For further information, please contact: Ståle Andreassen, CFO, +47 91 71 86 55 Anders S. Platou, Head of Corporate Finance & Strategy, +47 99 50 47 40 IR@bwoffshore.com or www.bwoffshore.com About BW Offshore: BW Offshore engineers innovative floating production solutions. The Company has a fleet of 8 FPSOs with potential and ambition to grow. By leveraging four decades of offshore operations and project execution, the Company creates tailored offshore energy solutions for evolving markets world-wide. BW Offshore has around 2,000 employees and is publicly listed on the Oslo Stock Exchange. This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act.
Jobindex A/S meddeler sin hensigt om afnotering og tilbud fra Danielsen 2 ApS til aktionærerne om køb af deres aktier til 1.900 kr. pr. aktie2.6.2023 20:16:00 CEST | pressemeddelelse
Selskabsmeddelelse nr. 6 / 2023 København, Danmark 2. juni 2023 – Jobindex A/S (“Jobindex” eller “Selskabet”), meddeler, at Jobindex i dag har besluttet at lade Selskabets aktier slette fra handel og officiel notering fra Nasdaq First North Growth Market Denmark (“Nasdaq First North”) og bemyndiget adm. direktør Kaare Danielsen til at indgive anmodning herom til Nasdaq Copenhagen A/S inden den 1. oktober 2023 samt at Danielsen 2 ApS (“Tilbudsgiver”) fremsætter et frivilligt ureguleret offentligt købstilbud på 1.900 kr. pr. aktie (det “Offentlige Købstilbud”) til alle aktionærer i Jobindex med undtagelse af Tilbudsgiver og Selskabet for så vidt angår egne aktier. For aktionærerne i Jobindex A/S betyder dette, at man har valget imellem at: Acceptere det Offentlige Købstilbud, der indebærer en præmie på ca. 8,6% ift. lukkekursen pr. 2. juni 2023 og en præmie på ca. 9,7% ift. de sidste 12 handelsdages volumenvægtede gennemsnitskurs (VWAP); ellerFortsætte uændret som aktionær i Jobindex A/S
Nokia Corporation: Repurchase of own shares on 02.06.20232.6.2023 20:00:00 CEST | Press release
Nokia Corporation Stock Exchange Release 2 June 2023 at 21:00 EEST Nokia Corporation: Repurchase of own shares on 02.06.2023 Espoo, Finland – On 2 June 2023 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows: Trading venue (MIC Code)Number of sharesWeighted average price / share, EUR*XHEL362,6953.83CEUX1,1353.84AQEU1,6303.81TQEX1,9403.81Total367,4003.83 * Rounded to two decimals On 3 February 2022, Nokia announced that its Board of Directors is initiating a share buyback program under the authorization granted by Nokia’s Annual General Meeting on 8 April 2021 to return up to EUR 600 million of cash to shareholders in tranches over a period of two years. The second phase of the share buyback program in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR), the Commission Delegated Regulation (EU) 2016/1052 and under the authorization granted by Nokia’s Annual General Meeting on 5 April 2022 started on 2 January 2023 and end
BlueCat acquires network infrastructure monitoring and automation platform Indeni2.6.2023 19:00:00 CEST | Press release
Customers will gain an enhanced ability to maintain network resiliency TORONTO, June 02, 2023 (GLOBE NEWSWIRE) -- BlueCat Networks, a leading provider of mission-critical network and cloud infrastructure software for reliable and secure DNS, DHCP, and IP address management (collectively known as DDI), announced today that it has acquired Indeni. Moelis & Company acted as financial advisors to BlueCat. Financial terms were not disclosed, and the deal is subject to regulatory approval. Indeni’s platform helps network operations (NetOps) teams assure the health of their network appliances such as firewalls, load balancers, and secure web proxies. It analyzes device configurations, metrics, and logs through deep domain expertise, codified as knowledge. And it alerts administrators about existing and potential issues, using a global, crowd-sourced knowledge base to identify and recommend remediation steps using automation. Customers using Check Point, Palo Alto Networks, Fortinet, F5, and m